St. Jude Medical (STJ) Shares are Down -5.99%

St. Jude Medical (STJ) : During the past 4 weeks, traders have been relatively bearish on St. Jude Medical (STJ), hence the stock is down -5.86% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -5.37% relative to the S&P 500. The 4-week change in the price of the stock is -6.06% and the stock has fallen -5.99% in the past 1 week.

Company shares have received an average consensus rating of Hold for the current week The stock has recorded a twenty day Moving Average of 6.05% and the fifty day Moving Average is 3.46%. St. Jude Medical Inc. is up 0.19% in the last three month period. Year-to-Date the stock performance stands at 27.53%.

St. Jude Medical (STJ) has been rated by 16 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $89 and the lowest price target forecast is $54. The average forecast of all the analysts is $76.09 and the expected standard deviation is $12.01.


St. Jude Medical (NYSE:STJ): stock turned positive on Friday. Though the stock opened at $77.71, the bulls momentum made the stock top out at $78.18 level for the day. The stock recorded a low of $75.34 and closed the trading day at $78.01, in the green by 0.24%. The total traded volume for the day was 13,183,950. The stock had closed at $77.82 in the previous days trading.

St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.